Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Equity Ratio (2016 - 2025)

Mimedx's Equity Ratio history spans 15 years, with the latest figure at 0.75 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 2.32% year-over-year to 0.75; the TTM value through Dec 2025 reached 0.75, up 2.32%, while the annual FY2025 figure was 0.75, 2.32% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.75 at Mimedx, roughly flat from 0.75 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.75 in Q1 2025 and bottomed at 0.11 in Q1 2023.
  • The 5-year median for Equity Ratio is 0.7 (2024), against an average of 0.41.
  • The largest annual shift saw Equity Ratio plummeted 24147.84% in 2022 before it skyrocketed 758.26% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.0 in 2021, then tumbled by 24147.84% to 0.1 in 2022, then skyrocketed by 668.98% to 0.6 in 2023, then increased by 22.56% to 0.73 in 2024, then grew by 2.32% to 0.75 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Equity Ratio are 0.75 (Q4 2025), 0.75 (Q3 2025), and 0.74 (Q2 2025).